InvestorsHub Logo
Followers 59
Posts 9079
Boards Moderated 0
Alias Born 08/20/2000

Re: None

Thursday, 05/23/2002 1:52:14 PM

Thursday, May 23, 2002 1:52:14 PM

Post# of 9
Venture Biodiscovery Announces Citrus Canker Treatment

ORLANDO, Fla., May 23 /PRNewswire-FirstCall/ -- Gatlin Holdings, Inc. (OTC Bulletin Board: GTNH) is excited to announce that its wholly-owned subsidiary, Venture Biodiscovery, Inc., has an "effective treatment" for combating citrus canker.


Venture Biodiscovery, Inc. established a laboratory in Florida to exploit the expertise of biodiscoverist, Robert M. Hysmith. In a statement from Dr. Robert Creger, CEO of Venture Biodiscovery, Inc.: "Citrus canker is an international problem for the citrus industry. Millions have been spent in Florida alone in combating this citrus disease following current standards. Dr. Hysmith has developed what we feel is an effective treatment for combating the bacterium that causes this devastating disease known as citrus canker. Currently, Venture Biodiscovery, Inc. is gearing up for field trial applications, and the mass production of its product."

Gatlin Holdings, Inc. is an opportunistic business specializing in the acquisition of entrepreneurial companies in need of infrastructure, funding, and public relations services. Gatlin's goal is to selectively acquire all types of companies and help them establish financial stability based upon sound business practices. Gatlin believes that this strategy will provide the greatest value for its shareholders.

For more information: Steven Burhoe, 407-658-9864.

SOURCE Gatlin Holdings, Inc.

/CONTACT: Steven Burhoe, +1-407-658-9864, for Gatlin Holdings, Inc./




.......According to the Great Pumpkin, ".....You're in .....iHub....., Charlie Brown....."!!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.